Жидкофазные дисперсные системы как основа микрогетерогенных полимерных матриц для трансдермальной доставки лекарств (1098267), страница 37
Текст из файла (страница 37)
Pharm.Sci. 2001. V.14, No2. P.101114.31. Hadgraft J. Percutaneous absorption: Possibilities and problems // Int. J. Pharm. 1983. V.16, No3. P.255270.32. Barry B.W. Skin transport // Dermatological formulations. Ed. Barry B.W. NewYork: Marcel&Dekker, 1983. P.95126.33. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential oftransdermal drug delivery // Nature Reviews Drug Discovery. 2004. V.3, No2. P.115124.34. Selvam R.P., Singh A.K. , Sivakumar T.
Transdermal drug delivery systems forantihypertensive drugs A review // Int. J. Pharm. Biomed. Res. 2010. V.1,No1. P.18.35. Agrawal S.S., Munjal P. Permeation studies of atenolol and metoprolol tartrate fromthree different polymer matrices for transdermal delivery // Indian J. Pharm. Sci. 2007. V.69, No4. P.535539.36.
Leo A., Hansch C., Elkins D. Partition coefficients and their uses // Chem. Rev. 1971. V.71, No6. P.525616.37. Sangster J. Octanol-water partition coefficients: fundamentals and physicalchemistry // Wiley Series in Solution Chemistry. Chichester: Johns Wiley & SonsLtd., 1997. V. 2. 178 p.23838. Franz T.J. Percutaneous absorption: On the relevance of in vitro data // J. Invest.Dermatol. 1975.
V.64, No3. P.190195.39. Franz S. W. Instrumentation and methodology for in vitro skin diffusion cells //Methodology for skin absorption. Eds. Kemppainen B.W., Reifenrath W.G. BocaRaton, Fla.: CRC Press, 1990. P.3559.40. Watkinson A.C., Brain K.R. Basic Mathematical Principles in Skin permeation //Dermatological and Transdermal Formulations.
Ed. Walters K. New York: MarcelDekker, 2002. P.6188.41. Smith K.L. Penetrant characteristics influencing skin absorption // Methods for skinabsorption. Eds. Kemppainen B.W., Reifenrath W.G. Boca Raton, Fla.: CRCPress, 1990. P.2433.42. Forster M., Bolzinger M.-A., Fessi Y., Briancon S. Topical delivery of cosmeticsand drugs. Molecular aspects of percutaneous absorption and delivery // Eur.
J.Dermatol. 2009. V.19, No4. P.309323.43. Flynn G.L. Physiochemical determinants of skin absorption // Principles of route-toroute extrapolation for risk assessment. Eds. Gerity T.R., Henry C.J. Amsterdam:Elsevier Science Publishing Co. Inc., 1990. P.93127.44. Potts R.O., Guy R.H. Predicting skin permeability // Pharm. Res. 1992. V.9,No5.
P.663669.45. Bronaugh R.L., Barton C.N. Prediction of human percutaneous absorption withphysiochemical data // Health risk assessment through dermal and inhalationexposure and absorption of toxicants. Eds. Wang R.G., Maibach H.I. Boca Raton,FL: CRC Press, 1991.
544 p.46. Guy R.H., Hadgraft J. Physicochemical aspects of percutaneous penetration and itsenhancement // Pharmaceutical Research. 1988. V.5, No12. P.753758.47. Willams A.C., Barry B.W. Penetration Enhancers // Adv. Drug Del. Rev. 2004. V.56, No5. P.603618.48. Flynn G.L., Stewart B. Percutaneous drug penetration: choosing candidates fortransdermal development // Drug Development Research. 1988. V.13, No23. P.169185.49. Barry B.W. Action of skin penetration enhancers the lipid protein partitioningtheory // Int.
J. of Cosmetic Science. 1988. V.10, No5. P.281293.50. Osborne D.W., Henke J.J. Skin penetration enhancers cited in the technicalliterature // Pharmaceutical Technology. 1997. V.21, No1. P.5866.23951. Trommer H., Neubert R.H.H. Overcoming the Stratum Corneum: the modulation ofskin penetration // Skin Pharmacol. Physiol. 2006. V.19, No2. P.106121.52. Sinha V.
R., Kaur M. P. Permeation enhancers for transdermal drug delivery // DrugDel. Ind. Pharm. 2000. V.26, No11. P.11311140.53. Saroha K., Yadav B., Sharma B. Transdermal patch: a discrete dosage form // Int. J.of Current Pharmaceutical Research. 2011. V.3, No3. P.98108.54. Barry B.W. Breaching the skin’s barrier to drugs // Nat. Biotechnol. – 2004.
– V.22,No2. – P.165–167.55. Mbah C.J., Uzor P.F., Omeje E.O. Perspectives on Transdermal Drug Delivery // J.Chem. Pharm. Res. 2011. V.3, No3. P.680700.56. Pathan I.B., Setty C.M. Chemical Penetration Enhancers for Transdermal DrugDelivery Systems // Tropical J. of Pharm. Research. 2009. V.8, No2. P.173179.57. Som I., Bhatia K., Yasir M.
Status of surfactants as penetration enhancers intransdermal drug delivery // J. Pharmacy Bioallied Sci. 2012. V.4, No1. P.29.58. Güngör S., Özsoy Y. Systematic delivery of antihypertensive drugs via skin //Therapeutic delivery.
2012. V.3, No9. P.11091116.59. Patel A.A., Trivedi D.G., Bhatt J.K., Shah D.A. Transdermal patches: a technicalnote // Int. J. of Pharmaceutical Innovations. 2012. V.2, No2. P.2333.60. Joshi S.C., Jasuja N.D. Enhancement of transdermal delivery system andantidiabetic approach: an overview // Int. J. of Pharmacy. 2012. V.2, No1. P.129141.61.
Шенфельд Н. Поверхностно-активные вещества на основе оксида этилена. М.: Химия, 1982. 748 с.62. Davies J.T., Rideal E.K. Interfacial phenomena. New York, London: Acad. Press,1963. 480 p.63. Kalbitz J., Neubert R. Modulation of drug penetration in the skin // Pharmazie. 1996. V.51, No9. P.619637.64. Prisada R., Dinu-Parvuz C. Modalities to enhance the transdermal penetration oftherapeutics of topic usage // Practica Pharmaceutica. 2012. V.5, No12. P.1722.65.
Willams A.C., Barry B.W. Terpenes and the lipid-protein partitioning theory of skinpenetration enyancers // Pharm. Res. 1991. V.8, No1. P.1724.24066. Kanikkannan N., Kandimalla K., Lamba S.S., Singh M. Structure-activityrelationship of chemical penetration enhancers in transdermal drug delivery // Curr.Med. Chem. 2000. V.7, No6. P.593608.67. Vávrová K., Hrabálek A., Doleźal P., Šámalová L., Palát K., Zbutovská J., et.al.Synthetic ceradide analogues as skin permeation enhancers: structure-activityrelationships // Bioorg. Med.
Chem. 2003. V.11, No24. P.53815390.68. Casiraghi A., Grigoli M.D., Cilurzo F., Gennari C.G.M., Rossoni G., Minghetti P.The Influence of the Polar Head and the Hydrophobic Chain on the Skin PenetrationEnhancement Effect of Poly(Ethylene Glycol) Derivatives // AAPS Pharm. Sci.Tech. 2012. V.13, No1. P.247253.69. Lopez A., Llinares F., Cortell C., Herraez M. Comparative enhancer effects of Span20 with Tween 20 and Azone on the in vitro percutaneous penetration ofcompounds with different lipophilicities // Int. J. of Pharmaceutics. 2000.
V.202,No12. P.133–140.70. Mohammadi-Samani S., Jamshidzadeh A., Montaseri H., Rangbar-Zahedani M.,Kianrad R. The effects of some permeability enhancers on the percutaneousabsorption of lidocaine // Pak. J. Pharm. Sci. 2010. V.23, No1. P.8388.71. Sheeba F.R., Giles D., S.K. Shivakumar Swamy S.K., Menaka T. Study onpermeation enhancement of sparfloxacin from certain selected ointment bases //Der. Pharmacia Lettre. 2012. V.4, No4. P.11151118.72. Akhtar N., Rehman M.U., Khan H.M.S., Rasool F., Saeed T., Murtaza G.Penetration enhancing effect of polysorbate 20 and 80 on the in vitro percutaneousabsorption of L-ascorbic acid // Tropical J.
of Pharmaceutical Research. 2011. V.10, No3. P.281288.73. Задымова Н.М., Ямпольская Г.П. Адсорбция поверхностно-активных веществ(ПАВ) на границах раздела фаз // Практикум по коллоидной химии. Ред.Куличихин В.Г. М.: Вузовский учебник: ИНФРА-М, 2012. Гл. 2. С.3580.74. Мицеллообразование, солюбилизация и микроэмульсии. Ред. Миттел К. М.:Мир, 1980. 597 с.75. Задымова Н.М., Ямпольская Г.П. Термодинамически устойчивые дисперсныесистемы // Практикум по коллоидной химии. Ред. Куличихин В.Г. М.:Вузовский учебник: ИНФРА-М, 2012. Гл.6.
С.141172.24176. Devraj N.S., Bhatt D.C., Aqil A.M., A review: different generation approaches oftransdermal drug delivery system // J. Chem. Pharm. Res. 2010. V.2, No4. P.184193.77. Tyagi R.K., Chandra A., Singh D., Rahman M.A. Transdermal drug delivery system(TDDS): an overview // Int. J. of Pharm. Sciences and Research. 2011. V.2,No6. P.13791388.78. Kandavilli S., Nair V., Panchagnula R. Polymers in transdermal drug deliverysystems // Pharmaceutical Technology. 2002. V.26, No1.
P.6380.79. Tiwary A.K., Sapra B., Jain S. Innovations in transdermal drug delivery:formulations and techniques // Recent Patents on Drug Delivery & Formulation. 2007. V.1, No1. P.2336.80. Shah S. Transdermal drug delivery technology revisited: recent advances // LatestReviews. 2008. V.6, No5. P.112.81.
Aggarwal G., Dhawan S. Development, Fabrication and Evaluation of TransdermalDrug Delivery System – A review // Pharmaceutical Reviews (www.pharminfo.net). 2009. V.7, No5. P.127.82. Gaur P. K., Mishra S., Purohit S., Dave K. Transdermal drug delivery system: areview // Asian J. of Pharm.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
